Susquehanna International Group, LLP Seres Therapeutics, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 1,192,749 shares of MCRB stock, worth $966,126. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,192,749

Previous 1,427,700 16.46%

Holding current value

$966,126

Previous $1.03 Million 10.32%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.7 - $1.48 $164,465 - $347,727	-234,951 Reduced 16.46%	1,192,749 $1.13 Million
Q2 2024 Aug 15, 2024	BUY	$0.56 - $1.19 $444,134 - $943,785	793,097 Added 124.98%	1,427,700 $1.03 Million
Q1 2024 May 07, 2024	SELL	$0.75 - $1.56 $582,335 - $1.21 Million	-776,447 Reduced 55.03%	634,603 $488,000
Q4 2023 Feb 14, 2024	BUY	$0.93 - $2.15 $1.08 Million - $2.5 Million	1,161,237 Added 464.84%	1,411,050 $1.98 Million
Q3 2023 Nov 14, 2023	SELL	$2.33 - $5.07 $10,545 - $22,946	-4,526 Reduced 1.78%	249,813 $594,000
Q2 2023 Aug 11, 2023	SELL	$4.67 - $6.55 $187,299 - $262,700	-40,107 Reduced 13.62%	254,339 $1.22 Million
Q1 2023 May 16, 2023	BUY	$4.95 - $6.09 $798,791 - $982,755	161,372 Added 121.26%	294,446 $1.67 Million
Q4 2022 Feb 14, 2023	SELL	$5.09 - $9.05 $128,680 - $228,793	-25,281 Reduced 15.96%	133,074 $745,000
Q3 2022 Nov 14, 2022	BUY	$3.5 - $7.2 $34,744 - $71,474	9,927 Added 6.69%	158,355 $1.02 Million
Q2 2022 Aug 15, 2022	SELL	$2.7 - $7.62 $122,534 - $345,818	-45,383 Reduced 23.42%	148,428 $509,000
Q1 2022 May 16, 2022	SELL	$6.3 - $8.84 $2.78 Million - $3.9 Million	-440,871 Reduced 69.46%	193,811 $1.38 Million
Q4 2021 Feb 14, 2022	BUY	$6.02 - $11.43 $1.71 Million - $3.24 Million	283,466 Added 80.71%	634,682 $5.29 Million
Q3 2021 Nov 15, 2021	BUY	$5.46 - $22.6 $1.56 Million - $6.46 Million	285,905 Added 437.76%	351,216 $2.44 Million
Q2 2021 Aug 11, 2021	SELL	$18.46 - $24.36 $822,042 - $1.08 Million	-44,531 Reduced 40.54%	65,311 $1.56 Million
Q1 2021 May 17, 2021	SELL	$17.66 - $28.92 $1.44 Million - $2.37 Million	-81,800 Reduced 42.68%	109,842 $2.26 Million
Q4 2020 Feb 16, 2021	BUY	$23.25 - $37.73 $1.98 Million - $3.22 Million	85,324 Added 80.25%	191,642 $4.7 Million
Q3 2020 Nov 16, 2020	BUY	$3.74 - $28.74 $290,186 - $2.23 Million	77,590 Added 270.08%	106,318 $3.01 Million
Q1 2020 May 15, 2020	SELL	$2.64 - $3.82 $8,408 - $12,166	-3,185 Reduced 9.98%	28,728 $102,000
Q4 2019 Feb 14, 2020	SELL	$2.99 - $4.42 $32,617 - $48,217	-10,909 Reduced 25.48%	31,913 $110,000
Q3 2019 Nov 14, 2019	BUY	$2.29 - $4.16 $30,232 - $54,920	13,202 Added 44.57%	42,822 $172,000
Q2 2019 Aug 16, 2019	BUY	$2.28 - $7.35 $24,001 - $77,373	10,527 Added 55.14%	29,620 $95,000
Q2 2019 Aug 14, 2019	SELL	$2.28 - $7.35 $29,783 - $96,013	-13,063 Reduced 40.62%	19,093 $61,000
Q4 2018 Feb 14, 2019	BUY	$4.52 - $8.88 $145,345 - $285,545	32,156 New	32,156 $145,000

Others Institutions Holding MCRB

# of Institutions

Shares Held

40.5M

Call Options Held

304K

Put Options Held

471K

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $100M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Seres Therapeutics, Inc. Transaction History